# Cheesecake Factory Inc: financial statements, quarterly

CAKE · Nasdaq · CIK 887596 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Dec 30

Pages: [Overview](/companies/cake.md) · [Financials](/companies/cake/financials.md) · [Filings](/companies/cake/filings.md) · [Insiders](/companies/cake/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/cake/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-10-03) | Q4 FY2023 (2024-01-02) | Q1 FY2024 (2024-04-02) | Q2 FY2024 (2024-07-02) | Q3 FY2024 (2024-10-01) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-04-01) | Q2 FY2025 (2025-07-01) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [830](/filings/0001410578-24-001742.md) | [877 d](/filings/0001104659-26-018643.md) | [891](/filings/0001410578-25-001073.md) | [904](/filings/0001410578-25-001564.md) | [865](/filings/0001104659-25-105631.md) | [921 d](/filings/0001104659-26-018643.md) | [927](/filings/0001104659-26-054987.md) | [956](/filings/0001104659-26-089840.md) | [907](/filings/0001104659-25-105631.md) | [962 d](/filings/0001104659-26-018643.md) | [979](/filings/0001104659-26-054987.md) | [1,030](/filings/0001104659-26-089840.md) |
| Cost of revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating income | $m | [19.0](/filings/0001410578-24-001742.md) | [8.1 d](/filings/0001104659-26-018643.md) | [39.3](/filings/0001410578-25-001073.md) | [58.7](/filings/0001410578-25-001564.md) | [33.7](/filings/0001104659-25-105631.md) | [46.6 d](/filings/0001104659-26-018643.md) | [52.0](/filings/0001104659-26-054987.md) | [64.8](/filings/0001104659-26-089840.md) | [37.3](/filings/0001104659-25-105631.md) | [33.2 d](/filings/0001104659-26-018643.md) | [55.0](/filings/0001104659-26-054987.md) | [78.6](/filings/0001104659-26-089840.md) |
| Interest expense | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [(0.9)](/filings/0001410578-24-001742.md) | [(7.0) d](/filings/0001104659-26-018643.md) | [4.3](/filings/0001410578-25-001073.md) | [3.9](/filings/0001410578-25-001564.md) | [1.8](/filings/0001104659-25-105631.md) | [4.2 d](/filings/0001104659-26-018643.md) | [1.5](/filings/0001104659-26-054987.md) | [7.4](/filings/0001104659-26-089840.md) | [3.6](/filings/0001104659-25-105631.md) | [1.9 d](/filings/0001104659-26-018643.md) | [3.8](/filings/0001104659-26-054987.md) | [8.5](/filings/0001104659-26-089840.md) |
| Net income | $m | [17.9](/filings/0001410578-24-001742.md) | [12.7 d](/filings/0001104659-26-018643.md) | [33.2](/filings/0001410578-25-001073.md) | [52.4](/filings/0001410578-25-001564.md) | [30.0](/filings/0001104659-25-105631.md) | [41.2 d](/filings/0001104659-26-018643.md) | [32.9](/filings/0001104659-26-054987.md) | [54.8](/filings/0001104659-26-089840.md) | [31.9](/filings/0001104659-25-105631.md) | [28.8 d](/filings/0001104659-26-018643.md) | [49.5](/filings/0001104659-26-054987.md) | [68.4](/filings/0001104659-26-089840.md) |
| Diluted EPS | $ per share | [0.37](/filings/0001410578-24-001742.md) | not reported | [0.68](/filings/0001410578-25-001073.md) | [1.08](/filings/0001410578-25-001564.md) | [0.61](/filings/0001104659-25-105631.md) | not reported | [0.67](/filings/0001104659-26-054987.md) | [1.14](/filings/0001104659-26-089840.md) | [0.66](/filings/0001104659-25-105631.md) | not reported | [1.02](/filings/0001104659-26-054987.md) | [1.41](/filings/0001104659-26-089840.md) |
| Basic EPS | $ per share | [0.37](/filings/0001410578-24-001742.md) | not reported | [0.70](/filings/0001410578-25-001073.md) | [1.10](/filings/0001410578-25-001564.md) | [0.63](/filings/0001104659-25-105631.md) | not reported | [0.69](/filings/0001104659-26-054987.md) | [1.18](/filings/0001104659-26-089840.md) | [0.68](/filings/0001104659-25-105631.md) | not reported | [1.06](/filings/0001104659-26-054987.md) | [1.47](/filings/0001104659-26-089840.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax, us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: not reported
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: not reported
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-10-03) | FY2023 (2024-01-02) | Q1 FY2024 (2024-04-02) | Q2 FY2024 (2024-07-02) | Q3 FY2024 (2024-10-01) | FY2024 (2024-12-31) | Q1 FY2025 (2025-04-01) | Q2 FY2025 (2025-07-01) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [64.0](/filings/0001104659-23-114808.md) | [56.3](/filings/0001410578-25-000195.md) | [60.2](/filings/0001410578-24-000636.md) | [40.7](/filings/0001410578-24-001151.md) | [52.2](/filings/0001410578-24-001742.md) | [84.2](/filings/0001104659-26-018643.md) | [135](/filings/0001410578-25-001073.md) | [149](/filings/0001410578-25-001564.md) | [190](/filings/0001104659-25-105631.md) | [216](/filings/0001104659-26-089840.md) | [235](/filings/0001104659-26-054987.md) | [195](/filings/0001104659-26-089840.md) |
| Current assets | $m | [272](/filings/0001104659-23-114808.md) | [301](/filings/0001410578-25-000195.md) | [284](/filings/0001410578-24-000636.md) | [278](/filings/0001410578-24-001151.md) | [287](/filings/0001410578-24-001742.md) | [333](/filings/0001104659-26-018643.md) | [361](/filings/0001410578-25-001073.md) | [379](/filings/0001410578-25-001564.md) | [424](/filings/0001104659-25-105631.md) | [455](/filings/0001104659-26-089840.md) | [465](/filings/0001104659-26-054987.md) | [419](/filings/0001104659-26-089840.md) |
| Total assets | $m | [2,777](/filings/0001104659-23-114808.md) | [2,840](/filings/0001104659-26-018643.md) | [2,838](/filings/0001410578-24-000636.md) | [2,880](/filings/0001410578-24-001151.md) | [2,936](/filings/0001410578-24-001742.md) | [3,042](/filings/0001104659-26-018643.md) | [3,111](/filings/0001410578-25-001073.md) | [3,152](/filings/0001410578-25-001564.md) | [3,241](/filings/0001104659-25-105631.md) | [3,262](/filings/0001104659-26-089840.md) | [3,297](/filings/0001104659-26-054987.md) | [3,294](/filings/0001104659-26-089840.md) |
| Current liabilities | $m | [619](/filings/0001104659-23-114808.md) | [661](/filings/0001410578-25-000195.md) | [655](/filings/0001410578-24-000636.md) | [643](/filings/0001410578-24-001151.md) | [652](/filings/0001410578-24-001742.md) | [711](/filings/0001104659-26-018643.md) | [684](/filings/0001410578-25-001073.md) | [737](/filings/0001410578-25-001564.md) | [771](/filings/0001104659-25-105631.md) | [777](/filings/0001104659-26-089840.md) | [781](/filings/0001104659-26-054987.md) | [714](/filings/0001104659-26-089840.md) |
| Total liabilities | $m | not reported | [2,522](/filings/0001410578-25-000195.md) | [2,505](/filings/0001410578-24-000636.md) | [2,506](/filings/0001410578-24-001151.md) | [2,539](/filings/0001410578-24-001742.md) | [2,598](/filings/0001104659-26-018643.md) | [2,771](/filings/0001410578-25-001073.md) | [2,751](/filings/0001410578-25-001564.md) | [2,816](/filings/0001104659-25-105631.md) | [2,825](/filings/0001104659-26-089840.md) | [2,838](/filings/0001104659-26-054987.md) | [2,775](/filings/0001104659-26-089840.md) |
| Long-term debt | $m | [470](/filings/0001104659-23-114808.md) | [470](/filings/0001410578-25-000195.md) | [471](/filings/0001410578-24-000636.md) | [471](/filings/0001410578-24-001151.md) | [472](/filings/0001410578-24-001742.md) | [452](/filings/0001104659-26-018643.md) | [627](/filings/0001410578-25-001073.md) | [560](/filings/0001410578-25-001564.md) | [560](/filings/0001104659-25-105631.md) | [561](/filings/0001104659-26-089840.md) | [562](/filings/0001104659-26-054987.md) | [563](/filings/0001104659-26-089840.md) |
| Current portion of debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [68.6](/filings/0001410578-25-001564.md) | [68.7](/filings/0001104659-25-105631.md) | [68.8](/filings/0001104659-26-089840.md) | [68.9](/filings/0001104659-26-054987.md) | not reported |
| Shareholders' equity | $m | [322](/filings/0001104659-23-114808.md) | [318](/filings/0001410578-25-000195.md) | [332](/filings/0001410578-24-000636.md) | [374](/filings/0001410578-24-001151.md) | [396](/filings/0001410578-24-001742.md) | [443](/filings/0001104659-26-018643.md) | [339](/filings/0001410578-25-001073.md) | [401](/filings/0001410578-25-001564.md) | [425](/filings/0001104659-25-105631.md) | [436](/filings/0001104659-26-089840.md) | [459](/filings/0001104659-26-054987.md) | [519](/filings/0001104659-26-089840.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-10-03) | Q4 FY2023 (2024-01-02) | Q1 FY2024 (2024-04-02) | Q2 FY2024 (2024-07-02) | Q3 FY2024 (2024-10-01) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-04-01) | Q2 FY2025 (2025-07-01) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [49.0 d](/filings/0001410578-24-001742.md) | [67.9 d](/filings/0001104659-26-018643.md) | [66.7](/filings/0001410578-25-001073.md) | [27.7 d](/filings/0001410578-25-001564.md) | [79.9 d](/filings/0001104659-25-105631.md) | [94.0 d](/filings/0001104659-26-018643.md) | [78.9](/filings/0001104659-26-054987.md) | [56.8 d](/filings/0001104659-26-089840.md) | [90.6 d](/filings/0001104659-25-105631.md) | [74.9 d](/filings/0001104659-26-018643.md) | [96.7](/filings/0001104659-26-054987.md) | [92.2 d](/filings/0001104659-26-089840.md) |
| Capital expenditure | $m | [37.3](/filings/0001410578-24-001742.md) | [51.6 d](/filings/0001104659-26-018643.md) | [37.1](/filings/0001410578-25-001073.md) | [29.2](/filings/0001410578-25-001564.md) | [54.2](/filings/0001104659-25-105631.md) | [39.9 d](/filings/0001104659-26-018643.md) | [42.8](/filings/0001104659-26-054987.md) | [41.5](/filings/0001410578-25-001564.md) | [36.7](/filings/0001104659-25-105631.md) | [25.2 d](/filings/0001104659-26-018643.md) | [43.4](/filings/0001104659-26-054987.md) | [42.9 d](/filings/0001104659-26-089840.md) |
| Dividends paid | $m | [13.1 d](/filings/0001410578-24-001742.md) | [13.1 d](/filings/0001104659-26-018643.md) | [12.8](/filings/0001410578-25-001073.md) | [13.9 d](/filings/0001410578-25-001564.md) | [13.1 d](/filings/0001104659-25-105631.md) | [13.2 d](/filings/0001104659-26-018643.md) | [12.5](/filings/0001104659-26-054987.md) | [14.3 d](/filings/0001104659-26-089840.md) | [12.6 d](/filings/0001104659-25-105631.md) | [12.8 d](/filings/0001104659-26-018643.md) | [14.2](/filings/0001104659-26-054987.md) | [15.7 d](/filings/0001104659-26-089840.md) |
| Share repurchases | $m | [14.6 d](/filings/0001410578-24-001742.md) | [9.8 d](/filings/0001104659-26-018643.md) | [12.5](/filings/0001410578-25-001073.md) | [3.9 d](/filings/0001410578-25-001564.md) | [1.1 d](/filings/0001104659-25-105631.md) | [0.8 d](/filings/0001104659-26-018643.md) | [141](/filings/0001104659-26-054987.md) | [0.1 d](/filings/0001104659-26-089840.md) | [1.2 d](/filings/0001104659-25-105631.md) | [11.2 d](/filings/0001104659-26-018643.md) | [18.4](/filings/0001104659-26-054987.md) | [11.0 d](/filings/0001104659-26-089840.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets, us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-27) | Q1 FY2023 (2023-04-04) | Q2 FY2023 (2023-07-04) | Q3 FY2023 (2023-10-03) | Q1 FY2024 (2024-04-02) | Q2 FY2024 (2024-07-02) | Q3 FY2024 (2024-10-01) | Q1 FY2025 (2025-04-01) | Q2 FY2025 (2025-07-01) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [49.7](/filings/0001104659-23-114808.md) | [49.8](/filings/0001410578-24-000636.md) | [49.1](/filings/0001410578-24-001151.md) | [49.0](/filings/0001410578-24-001742.md) | [48.7](/filings/0001410578-25-001073.md) | [48.8](/filings/0001410578-25-001564.md) | [48.9](/filings/0001104659-25-105631.md) | [49.3](/filings/0001104659-26-054987.md) | [48.1](/filings/0001104659-26-089840.md) | [48.6](/filings/0001104659-25-105631.md) | [48.5](/filings/0001104659-26-054987.md) | [48.5](/filings/0001104659-26-089840.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 49,760,634 at 2026-07-27, from the cover of the [10-Q filed 2026-08-03](/filings/0001104659-26-089840.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:27 ET. No prices; not investment advice.